top of page

Keeping the heart young

Keeping the heart young

Pioneering
            better worlds

There is no cure for Heart Failure. We will change that. 

> Mission, critical.

There is no cure for Heart Failure

  • 7 million Americans have Heart Failure, 60 million people world-wide

  • The 5-year mortality rate upon Heart Failure diagnosis is 50%, worse than most cancers

  • Standard of Care largely addresses the symptoms of Heart Failure, not the root cause​​

We are developing novel therapeutics that address the core, molecular, underpinnings of cardiac muscle pathology to inhibit and reverse Heart Failure development and progression. 

​

Mother and Daughter Love

> Team.

Root to Canopy. Our leadership team brings talent, ideas, and experience from their time as clinicians on the front line,

scientists at top academic research institutions, and shepherds of cardiovascular pipelines in both biotech and big pharma. ​​

Seed to Ecosystem. Supporting our therapeutic programs is a world-class Scientific Advisory Board        and leading experts in RNAi, oligo chemistry, and conjugated-mediated drug delivery to the heart. 

Scientific Advisory Board

> Pipeline.

Right Target, Right Disease, Right Modification, Right Modality. Our pipeline currently consists of two RNA-based therapeutic strategies, supported by strong foundational IP, that target two unique molecular mechanisms where there is deep scientific and clinical rationale to improve patient outcomes. 

Essential Waves
bottom of page